- Home
- AU vs WST Comparison
AU vs WST Comparison
Compare AU & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- WST
- Stock Information
- Founded
- AU 1944
- WST 1923
- Country
- AU United States
- WST United States
- Employees
- AU N/A
- WST 10600
- Industry
- AU Precious Metals
- WST Medical/Dental Instruments
- Sector
- AU Basic Materials
- WST Health Care
- Exchange
- AU Nasdaq
- WST Nasdaq
- Market Cap
- AU 21.5B
- WST 15.2B
- IPO Year
- AU 1972
- WST N/A
- Fundamental
- Price
- AU $43.25
- WST $201.90
- Analyst Decision
- AU Hold
- WST Strong Buy
- Analyst Count
- AU 5
- WST 6
- Target Price
- AU $36.80
- WST $349.00
- AVG Volume (30 Days)
- AU 3.6M
- WST 983.4K
- Earning Date
- AU 05-06-2025
- WST 04-24-2025
- Dividend Yield
- AU 2.11%
- WST 0.40%
- EPS Growth
- AU N/A
- WST N/A
- EPS
- AU 2.33
- WST 6.69
- Revenue
- AU $5,793,000,000.00
- WST $2,893,200,000.00
- Revenue This Year
- AU $35.82
- WST $0.96
- Revenue Next Year
- AU $3.58
- WST $6.64
- P/E Ratio
- AU $18.56
- WST $30.18
- Revenue Growth
- AU 26.43
- WST N/A
- 52 Week Low
- AU $21.65
- WST $187.43
- 52 Week High
- AU $46.90
- WST $394.42
- Technical
- Relative Strength Index (RSI)
- AU 67.35
- WST 36.70
- Support Level
- AU $31.91
- WST $187.43
- Resistance Level
- AU $46.90
- WST $214.62
- Average True Range (ATR)
- AU 1.76
- WST 10.57
- MACD
- AU 0.77
- WST 0.95
- Stochastic Oscillator
- AU 75.65
- WST 37.92
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.